Physician profile
Brian Asencio
NPI 1063866242
$5,897.74
in general payments reported to CMS, 2019-2025
13 companies · $355 in 2025
The $355 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $751 · 2020: $967 · 2021: $2,605 · 2022: $324 · 2023: $217 · 2024: $678 · 2025: $355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,250.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,661.79 | 2019-2021 | |
| Paragon 28, INC. | $1,324.28 | 2020-2021 | |
| Stryker Corporation | $1,296.76 | 2019-2025 | Salvation, Ortholoc 3di, Easyfuse |
| Southern Edge Orthopaedics, INC. | $645.19 | 2020 | |
| Medical Device Business Services, INC. | $269.98 | 2019 | |
| Integra Lifesciences Corporation | $180.28 | 2019-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Penumbra, INC. | $143.57 | 2024 | Indigo System |
| Depuy Synthes Sales INC. | $115.16 | 2019-2025 | Na |
| Polynovo North America LLC | $100.71 | 2025 | Novosorb Btm |
| Acera Surgical, INC. | $71.04 | 2024 | Restrata Wound Matrix |
| Bone Support INC. | $57.48 | 2024 | Cerament G, Ceramentbone Void Filler |
| Paratek Pharmaceuticals, INC. | $18.00 | 2021 | |
| Smith+Nephew, INC. | $13.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Asencio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.